Compare Build A Bear Workshop Inc (BBW) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Build A Bear Workshop Inc vs BioNano Genomics Inc — how do they compare? Build A Bear Workshop Inc trades at $36.97 (market cap $461.88M), while BioNano Genomics Inc trades at $1.19 (market cap $13.66M). The key difference: Build A Bear Workshop Inc is far larger — about 33.8× BioNano Genomics Inc's market cap, and Build A Bear Workshop Inc pays a 2.5% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BBW | BNGO | |
|---|---|---|
Market Cap | $461.88M | $13.66M |
Sector | Consumer Cyclical | Health |
52-Week High | $75.85 | $4.92 |
52-Week Low | $29.84 | $1.06 |
Enterprise Value | $561.32M | $16.26M |
Dividend Yield | 2.5% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Build-A-Bear Workshop (BBW) trades at $36.09, down 3.14% today, but maintains strong fundamentals with a P/E of 8.63 and robust profitability metrics including 35.87% ROE. The stock shows technical bullish signals with moving averages supporting upward momentum, though RSI levels suggest potential near-term overbought conditions. Recent earnings beats and strategic product launches position the company for continued growth despite current price weakness.
BBW presents compelling value with analyst consensus price target of $62.50 representing 73% upside potential. The debt-free balance sheet, consistent dividend payments, and international expansion strategy support long-term growth, though near-term consumer spending pressures and competitive retail environment pose execution risks for investors.
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Build A Bear Workshop Inc
Build-A-Bear is a global retailer specializing in customizable stuffed animals. It offers an interactive make-your-own experience where customers choose, stuff, and dress their furry friends in-store or online.
Read more on BBW →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
